Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
33,229
+28,138
+553% +$1.71M 0.02% 756
2026
Q1
$249K Buy
+5,091
New +$238K ﹤0.01% 1348
2025
Q2
Sell
-91,814
Closed -$2.74M 1514
2025
Q1
$2.74M Buy
+91,814
New +$3.23M 0.03% 590
2024
Q1
Sell
-13,791
Closed -$576K 1532
2023
Q4
$576K Sell
13,791
-46,905
-77% -$1.8M ﹤0.01% 995
2023
Q3
$2.58M Buy
60,696
+30,771
+103% +$1.51M 0.02% 597
2023
Q2
$1.68M Buy
+29,925
New +$1.55M 0.01% 881
2022
Q3
Sell
-70,891
Closed -$3.01M 1925
2022
Q2
$3.01M Buy
+70,891
New +$3.97M 0.04% 607
2022
Q1
Sell
-34,618
Closed -$2.69M 2236
2021
Q4
$2.69M Buy
34,618
+11,609
+50% +$937K 0.03% 639
2021
Q3
$1.85M Sell
23,009
-24,078
-51% -$2.07M 0.02% 753
2021
Q2
$3.96M Buy
47,087
+28,476
+153% +$2.3M 0.04% 438
2021
Q1
$1.54M Buy
18,611
+5,775
+45% +$481K 0.02% 685
2020
Q4
$1.03M Sell
12,836
-13,769
-52% -$1M 0.01% 845
2020
Q3
$1.73M Buy
+26,605
New +$1.72M 0.03% 455
2020
Q1
Sell
-4,770
Closed -$267K 1133
2019
Q4
$267K Buy
+4,770
New +$247K 0.01% 1207

Other funds holding CGNX

Michael Gelband's CGNX Position: Q2 2026 in Review

Michael Gelband increased its Cognex (CGNX) stake by 553% in Q2 2026, buying an estimated $1.71M and bringing the position to 33,229 shares worth $2.41M. The position accounts for 0.02% of the portfolio, ranked #756.

Michael Gelband first reported a position in CGNX in Q4 2019 and has held it in 14 quarters since. The position peaked at $3.96M in Q2 2021. 648 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Michael Gelband held 33,229 shares of Cognex worth $2.41M as of Q2 2026.
  • Michael Gelband bought 28,138 Cognex shares in Q2 2026, an estimated $1.71M.
  • Cognex made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #756 holding.
  • Michael Gelband first reported a position in Cognex in Q4 2019 and has held it in 14 quarters since.
  • Michael Gelband's Cognex position peaked at $3.96M in Q2 2021.
  • 648 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.